Search The Medical Knowledge Base
Medical News by Category
Hepatitis C News
- FDA halts alisporivir (Novartis) Phase III trial
Published: Tuesday 24 April 2012
- EMERGE study of Lambda (BMS) in Hepatitis C genotypes 2 and 3 presented at EASL
Published: Sunday 22 April 2012
- Phase IIa results for Miravirsen (Santaris Pharma) show prolonged antiviral activity in Hepatitis C patients
Published: Friday 20 April 2012
- Phase IIb data show SVR12 in Hepatitis C patients treated with BI 201335 (Boehringer Ingelheim)
Published: Friday 20 April 2012
- ABT-450.r plus ABT 333 Phase II studies in Hepatitis C announced by Abbott Labs
Published: Wednesday 04 April 2012
- NICE recommends Incivo (J&J Janssen Cilag) for genotype 1 chronic Hepatitis C patients
Published: Friday 23 March 2012
- TMC 435 (Medivir) begins two new Phase III trials for Hepatitis C
Published: Wednesday 14 March 2012
- NICE endorses Victrelis (Merck Inc.)for Hepatitis C genotype 1 infection
Published: Saturday 10 March 2012
- Daclatasvir plus asunaprevir(BMS) in Phase II Hepatitis C trial
Published: Thursday 19 January 2012
- BI-201335 (Boehringer Ingelheim) Phase III trial completes recruitment
Published: Wednesday 14 December 2011
- Patients with Chronic Hepatitis C may benefit from Victrelis (Merck) but extent unclear
Published: Wednesday 14 December 2011
- Daclatasvir (BMS) and TME 435(Tibotec) combination for Phase II for Hepatitis C
Published: Monday 05 December 2011
- Vertex Pharma starts Phase IIIb trial in genoytpe 1 Hepatitis C patients who have 'CC' variation near the IL28B gene
Published: Wednesday 26 October 2011
- Incivo will launch in Germany first for Hepatitis C
Published: Sunday 25 September 2011
- Incivek treatment still effective when course is half as long in treatment of Hepatitis C genotype 1
Published: Monday 19 September 2011
- IlLLUMINATE trial of Incivek is published in NEJM
Published: Saturday 17 September 2011
- BI 201335 enters Phase III for Hepatitis C
Published: Saturday 30 April 2011
- Phase II data for BI 201335 for Hepatitis C
Published: Saturday 02 April 2011
- Phase II b EMERGE study of PEG-interferon lambda in Hepatitis C
Published: Saturday 02 April 2011